Growth Metrics

electroCore (ECOR) Total Debt (2017 - 2026)

electroCore's quarterly Total Debt came in at $6.7 million in Q1 2026, up 1.21% quarter-over-quarter from $6.6 million in Q4 2025.

electroCore has reported Total Debt for 5 years, with the latest figure at $6.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Debt changed N/A year-over-year to $6.7 million; the trailing twelve-month figure through Mar 2026 stood at $6.7 million (changed N/A YoY), and the FY2025 full-year result was $6.6 million, changed N/A from the prior year.
  • Total Debt for Q1 2026 stood at $6.7 million, up from $6.6 million in the prior quarter.
  • The five-year high for Total Debt was $6.7 million in Q1 2026, with the low at $6.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 34.05 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 14.72 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 28.07 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 11.03 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 598.50 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 8.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.93 Bn
10 electroCore 92,394.96 -8.79 Mn 8.36 Mn 6.69 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 6.69 Mn
Dec 31, 2025 6.61 Mn
Sep 30, 2025 6.53 Mn
Mar 31, 2021 863,799.00
Dec 31, 2020 1.10 Mn
Sep 30, 2020 1.33 Mn
Jun 30, 2020 858,114.00
Dec 31, 2017 2.24 Mn